A rare case of atypical bone marrow sarcoidosis without pulmonary involvement in a Japanese woman
- 1 Internal Medicine, Mishuku Hospital, Megro, Japan
- 2 Department of Internal Medicine, Self-Defence Forces Central Hospital, Setagaya, Japan
- 3 Department of Pathology, Self-Defence Forces Central Hospital, Setagaya, Japan
- Correspondence to Maki Iwata; 1254maki@gmail.com
Abstract
Sarcoidosis is a systemic granulomatous disease of unknown origin characterised by the presence of non-caseating granulomatous lesions. Extrapulmonary sarcoidosis with bone marrow involvement is rare and even more so without pulmonary involvement. Here, we describe a case of 69-year-old woman diagnosed as having bone marrow and hepatic sarcoidosis without pulmonary involvement based on 18F-fluorodeoxyglucose positron emission tomography findings. She was successfully treated with systemic glucocorticoid therapy.
Background
Sarcoidosis is a multisystemic disease characterised by defective cell-mediated immunity with formation of non-caseating granulomas in various organ systems. The lungs and mediastinal lymph nodes are most commonly affected, as seen in more than 90% of sarcoidosis cases. Moreover, less than 0.5% of sarcoidosis cases with bone marrow involvement also have pulmonary involvement. Therefore, bone marrow sarcoidosis without pulmonary involvement is very rare. Here, we report a case of bone marrow and hepatic sarcoidosis without pulmonary involvement in a Japanese woman whose symptoms were fever, night sweats and weight loss.
Case presentation
Having only hypertension and hyperlipidaemia in the medical history, a 69-year-old woman presented with fever of unknown origin, night sweats and weight loss, which had persisted for 2 months. She experienced weight loss of 5 kg over this period. Her medical history was notable for hypertension and hyperlipidaemia.
On admission, her temperature was 38.5°C and heart rate was 101 bpm. On clinical examination, there was no disturbance of consciousness, tendon reflexes were normal and no pathological reflexes were noted.
She had no rashes, subcutaneous nodules or postinflammatory skin changes. No psoriatic nail changes were seen. The salivary glands were not enlarged, and there was no palpable systemic lymphadenopathy.
Investigations
On admission, aspartate aminotransferase was 44 U/L, alanine transaminase was 36 U/L, alkaline phosphatase was 1613 U/L, hepatic enzymes were partialy elevated and function was normal. Serum calcium level was 10.3 mg/dL. C reactive protein level was increased (6.02 mg/dL; reference: <0.3 mg/dL), as was erythrocyte sedimentation rate (64 mm/hour). There was an increase in soluble interleukin-2 receptor (IL-2R): 4030 U/mL; no increase of ACE level: 15.8 U/L. Antinuclear antibody titre was less than 1:40. Both myeloperoxidase–antineutrophil cytoplasmic antibody and proteinase-3 antineutrophil cytoplasmic antibody titres were less than 1:40, and interferon-gamma release assay was negative. Blood culture was also negative. Immunoglobulin G (IgG) was slightly elevated (1858 mg/dL), but IgG4 was normal (31.0 mg/dL). There were no specific electrocardiographic findings and echocardiogram findings. CT scan of the chest did not show any evidence of pneumonia or perimediastinal or hilar lymphadenopathy. 18F-fluorodeoxyglucose-positron emission tomography (FDG-PET) scans showed uptake in multiple hypermetabolic osseus lesions in both shoulders, the wrist, the whole pelvis and multiple vertebral bodies (figure 1). In addition, there was increased uptake in the spleen and liver. Therefore, we performed liver biopsy and bone marrow biopsy at right posterior superior iliac crest, which revealed non-caseating epithelioid granulomas (figures 2 and 3). No findings suggestive of vasculitis, malignancy and lymphoma were noted. Transbronchial lung biopsy revealed no findings of granulomatous tissue and the CD4/CD8 ratio was 1.63 in bronchoalveolar lavage fluid taken from the middle lobe. Within the scope of our investigations, no findings suggested infectious disease. Opthalmologic findings were normal. These clinical features were compatible with a diagnosis of sarcoidosis.
FDG-PET images. FDG-PET scan shows diffusely increased focal FDG uptake localised to multiple bone lesions, including the whole pelvis and to multiple lesions in the liver, the spleen and some joints. We performed bone marrow biopsy at right posterior superior iliac crest. FDG-PET, 18F-fluorodeoxyglucose-positron emission tomography.

Liver biopsy. This section shows an epithelioid cell granuloma, which is a compact formation of molecular phagocytes in the lobular and periportal distributions. There is no evidence of malignancy or primary biliary cirrhosis. H&E stain, ×300.

Bone marrow biopsy. This section shows epithelioid cell granulomas, some of which include Langerhans giant cells. There is no evidence of lymphoma or a massive increase in blastoid cells. H&E stain, ×300.

We obtained granulomatous tissues where FDG-PET showed areas of inflammation, showing consistency between the clinical and radiographic manifestations. In addition, we excluded diseases that may present similarly to sarcoidosis, including malignant lymphoma, infectious diseases and autoimmune diseases. Histopathological examination revealed non-caseating granulomas. Therefore, we diagnosed her illness as sarcoidosis.
Differential diagnosis
Based on the clinical symptoms, the increase in IL-2R and the FDG-PET findings, malignant lymphoma was the most important differential diagnosis. However, the liver and bone marrow biopsy findings did not show atypical lymphocytes. In the differential diagnosis of granulomas found in pathological examinations, infectious and autoimmune diseases should be focused on. In particular, tuberculosis, endemic fungal diseases, viral hepatitis, toxoplasmosis, cat scratch disease and syphilis should be considered as infectious diseases. However, the results of serological tests and contact history were not compatible with these possible diagnoses. Autoimmune disorders that can cause liver and bone marrow granulomatous inflammation include Langerhans cell histocytosis, IgG4-related disease. Our patient had no evidence of Langerhans cell histocytosis on biopsy and no characteristic findings of IgG4-related disease.
Treatment
Prednisolone was administered for 3 days at an initial dose of 30 mg/day (0.5 mg/kg/day). Her symptoms, including fever and general malaise, gradually improved. Thereafter, the dose was tapered by 5 mg/week while checking that the symptoms did not worsen. After the dose reached 15 mg/day, the tapering interval was reduced to 2.5 mg/week.
Outcome and follow-up
She was discharged on day 58 and was followed up on an outpatient basis at our hospital. She became diabetic and began taking hypoglycaemic medication. She is now taking prednisolone 5 mg/day as an outpatient and her progress has been good as of this writing.
Discussion
The diagnosis of sarcoidosis is not standardised but is based on three major criteria: a compatible clinical presentation, finding non-necrotising granulomatous inflammation in one or more tissue samples, and the exclusion of alternative causes of granulomatous disease.1
We considered the differential diagnoses as described above, and excluded them based on the clinical course, the absence of insect bites, successful glucocorticoid therapy and pathological findings.
The lungs are the most commonly affected site in sarcoidosis. Only about 8% of patients with sarcoidosis have extrapulmonary involvement without pulmonary involvement.2 Moreover, bone marrow involvement in sarcoidosis is even less common, occurring in only 3%–5% of sarcoidosis patients.3 We encountered a patient who had bone marrow and hepatic sarcoidosis without pulmonary involvement, which is very rare.
The main clinical features of bone sarcoidosis are pain, reduced exercise tolerance, numbness, swelling and finger deformity. Swelling and hand deformity are common features of appendiceal bone involvement.4 This case was unusual in that the patient had no pain and presented with fatigue and high-grade fever. Ultimately, we detected bone marrow involvement on FDG-PET. In a previous study, 26 of 64 patients with bone marrow sarcoidosis (40.6%) were asymptomatic, and bone lesions were detected incidentally PET/CT imaging in 15 of these patients (57.7%). These results are consistent with another recent study, which demonstrated that more than one-third of patients with sarcoidosis with positive PET/CT findings had bone abnormalities.5 This observation suggests that PET/CT scanning in asymptomatic sarcoidosis patients enables better assessment of the granulomatous burden, including bone abnormalities.
To date, there is no pathognomonic biomarker for confirming the diagnosis of sarcoidosis. Serological markers, such as serum ACE, adenosine deaminase, serum amyloid A, soluble IL-2R and D-dimer, have been examined for potential roles in diagnosis or monitoring of disease activity, but no clear evidence of their utility has been found.6 The ACE level is elevated in 75% of untreated patients with sarcoidosis.7 However, serum ACE has limited diagnostic utility due to poor sensitivity (false negatives) and insufficient specificity, with a false positive rate of almost 10%.7–9 The value of monitoring ACE levels to assess the course of the disease remains unclear. On the other hand, serum soluble IL-2R has been suggested as a useful marker for identifying extrapulmonary involvement in sarcoidosis patients.6 10 In our case, the serum ACE level was normal and only soluble IL-2R was elevated.
Our case showed a good response to systemic glucocorticoid therapy, and there has been no recurrence as of this writing. Because of the lack of biomarkers and general imaging findings such as CT scans for confirming the diagnosis of extrapulmonary sarcoidosis, as well as the lack of specific symptoms in many patients, it is essential to always keep in mind the possibility of sarcoidosis in patients with fever of unknown origin.
Patient’s perspective
I understand my disease is rare. I would like to be useful for medicine of all over the world.
Learning points
-
We encountered a rare case of sarcoidosis with bone marrow and hepatic involvement but no lung and mediastinal lesions.
-
Sarcoidosis should always be considered as a differential diagnosis, in patients with fever of unknown origin.
-
Positron emission tomography/CT is useful for detecting and localising sites of inflammation, particularly in bone marrow sarcoidosis.
Ethics statements
Acknowledgments
I am grateful to the members of the Department of Hematology in Mishuku Hospital and Dr Kichikawa for collaboration.
Footnotes
-
Contributors MI wrote the initial draft of the manuscript. TK, HT and NM assisted in the preparation of the manuscript. All authors approved the final version of the manuscript and agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
-
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
-
Competing interests None declared.
-
Provenance and peer review Not commissioned; externally peer reviewed.
- © BMJ Publishing Group Limited 2021. No commercial re-use. See rights and permissions. Published by BMJ.
References
Use of this content is subject to our disclaimer